These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. APOE allele frequencies in demented and nondemented elderly Jamaicans. Morgan OS; Eldemire DA; Thesiger CH; Luseko J; Sahota A; Gao S; Hall KS; Hendrie HC Ann Neurol; 1998 Apr; 43(4):545. PubMed ID: 9546341 [No Abstract] [Full Text] [Related]
3. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E polymorphism in India: high APOE*E3 allele frequency in Ramgarhia of Punjab. Singh P; Singh M; Gerdes U; Mastana SS Anthropol Anz; 2001 Mar; 59(1):27-34. PubMed ID: 11360807 [TBL] [Abstract][Full Text] [Related]
5. [Apolipoprotein E genotypes in patients investigated for dementia]. Johannsen P; Jakobsen JK; Jørgensen AL Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E phenotype in demented patients in Greek population. Hatzifilippou E; Banaki T; Traka M; Koutsouraki E; Costa V; Baloyannis SJ Int J Neurosci; 2008 Jan; 118(1):163-72. PubMed ID: 18041613 [TBL] [Abstract][Full Text] [Related]
7. Changes in phenotypes of apolipoprotein E and apolipoprotein(a) in liver transplant recipients. Fernández-Miranda C; Cancelas P; de la Calle A; Gómez R; Moreno E; Gómez-Gerique J; del Palacio A Clin Transplant; 1997 Aug; 11(4):325-7. PubMed ID: 9267723 [TBL] [Abstract][Full Text] [Related]
8. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients. Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Davignon J; Bouthillier D; Nestruck AC; Sing CF Trans Am Clin Climatol Assoc; 1988; 99():100-10. PubMed ID: 3503432 [No Abstract] [Full Text] [Related]
10. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Forsell Y; Corder EH; Basun H; Lannfelt L; Viitanen M; Winblad B Biol Psychiatry; 1997 Nov; 42(10):898-903. PubMed ID: 9359975 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Zareparsi S; Kaye J; Camicioli R; Grimslid H; Oken B; Litt M; Nutt J; Bird T; Schellenberg G; Payami H Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478 [TBL] [Abstract][Full Text] [Related]
12. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Geschwind D; Karrim J; Nelson SF; Miller B Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603 [TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of the frequency of the apolipoprotein E-epsilon 4 allele in the European population]. Beránek M; Friedecký B; Palicka V Cas Lek Cesk; 1999 Aug; 138(16):500-3. PubMed ID: 10566228 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese. Wong SY; Lau EM; Li M; Chung T; Sham A; Woo J J Bone Miner Metab; 2005; 23(3):261-5. PubMed ID: 15838630 [TBL] [Abstract][Full Text] [Related]